Vanda Pharmaceuticals reported $12.6M in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.4M 23.03M
Acorda Therapeutics ACOR:US $ -28.7M 9.15M
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Akebia Therapeutics AKBA:US $ -83.04M 13.46M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Anika Therapeutics ANIK:US $ 9.13M 7.92M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Clovis Oncology CLVS:US $ -66.45M 0.04M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Enanta Pharmaceuticals ENTA:US $ -33.41M 4.25M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Halozyme Therapeutics HALO:US $ 91.52M 36.81M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Insmed INSM:US $ -116699000 25.3M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Johnson & Johnson JNJ:US $ 8058M 282M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Minerva Neurosciences NERV:US $ -10.59M 3.08M
Moderna Inc MRNA:US 3.06B 1.8B
Novartis NVS:US $ 4424M 361M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Sanofi SAN:FP € 2180M 376M
Teva Pharmaceutical TEVA:IT 794M 650M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Vanda Pharmaceuticals VNDA:US $ 12.6M 2.18M
Veracyte VCYT:US $ 9.19M 19.75M